JP Morgan Chase
NXGN

JP Morgan Chase’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

JP Morgan Chase’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-120,782
Closed -$2.87M – 8058
2023
Q3 		$2.87M Sell
120,782
-211,306
-64% -$3.98M ﹤0.01% 3269
2023
Q2 		$5.39M Buy
332,088
+54,210
+20% +$898K ﹤0.01% 2803
2023
Q1 		$4.84M Sell
277,878
-142,154
-34% -$2.56M ﹤0.01% 2850
2022
Q4 		$7.89M Sell
420,032
-1,345,360
-76% -$25.9M ﹤0.01% 2460
2022
Q3 		$31.2M Sell
1,765,392
-65,992
-4% -$1.15M ﹤0.01% 1297
2022
Q2 		$31.9M Sell
1,831,384
-36,602
-2% -$698K ﹤0.01% 1292
2022
Q1 		$39.1M Buy
1,867,986
+226,598
+14% +$4.34M ﹤0.01% 1308
2021
Q4 		$29.2M Buy
1,641,388
+780,320
+91% +$12.5M ﹤0.01% 1506
2021
Q3 		$12.1M Sell
861,068
-36,972
-4% -$575K ﹤0.01% 2211
2021
Q2 		$14.9M Buy
898,040
+395,354
+79% +$7.08M ﹤0.01% 2078
2021
Q1 		$9.1M Buy
502,686
+89,388
+22% +$1.76M ﹤0.01% 2450
2020
Q4 		$7.54M Buy
413,298
+114,187
+38% +$1.81M ﹤0.01% 2443
2020
Q3 		$3.79M Sell
299,111
-26,598
-8% -$340K ﹤0.01% 2787
2020
Q2 		$3.58M Buy
325,709
+238,537
+274% +$2.47M ﹤0.01% 2712
2020
Q1 		$910K Sell
87,172
-797
-0.9% -$10.3K ﹤0.01% 3453
2019
Q4 		$1.41M Sell
87,969
-23,312
-21% -$385K ﹤0.01% 3629
2019
Q3 		$1.74M Buy
111,281
+67,705
+155% +$1.13M ﹤0.01% 3512
2019
Q2 		$831K Sell
43,576
-10,891
-20% -$203K ﹤0.01% 3968
2019
Q1 		$917K Sell
54,467
-20,012
-27% -$347K ﹤0.01% 3856
2018
Q4 		$1.13M Sell
74,479
-59,865
-45% -$1.03M ﹤0.01% 3667
2018
Q3 		$2.7M Buy
134,344
+14,063
+12% +$298K ﹤0.01% 3247
2018
Q2 		$2.35M Buy
120,281
+48,941
+69% +$774K ﹤0.01% 3301
2018
Q1 		$974K Sell
71,340
-21,258
-23% -$280K ﹤0.01% 3683
2017
Q4 		$1.26M Buy
92,598
+54,723
+144% +$786K ﹤0.01% 3590
2017
Q3 		$588K Sell
37,875
-46,298
-55% -$747K ﹤0.01% 3770
2017
Q2 		$1.45M Sell
84,173
-42,396
-33% -$644K ﹤0.01% 3238
2017
Q1 		$1.93M Buy
126,569
+125,951
+20,380% +$1.85M ﹤0.01% 3055
2016
Q4 		$8K Buy
+618
New +$7.92K ﹤0.01% 4828
2016
Q3 		– Sell
-462,775
Closed -$5.51M – 4883
2016
Q2 		$5.51M Buy
462,775
+97,712
+27% +$1.31M ﹤0.01% 2223
2016
Q1 		$5.56M Buy
365,063
+325,876
+832% +$4.94M ﹤0.01% 2144
2015
Q4 		$631K Sell
39,187
-24,033
-38% -$351K ﹤0.01% 3307
2015
Q3 		$789K Sell
63,220
-118,200
-65% -$1.62M ﹤0.01% 3231
2015
Q2 		$3.01M Buy
181,420
+8,700
+5% +$140K ﹤0.01% 2675
2015
Q1 		$2.76M Buy
172,720
+122,436
+243% +$2.02M ﹤0.01% 2708
2014
Q4 		$784K Buy
+50,284
New +$735K ﹤0.01% 3473
2014
Q1 		– Sell
-57,757
Closed -$1.22M – 4002
2013
Q4 		$1.22M Sell
57,757
-1,467
-2% -$33.1K ﹤0.01% 3051
2013
Q3 		$1.29M Sell
59,224
-9,377
-14% -$200K ﹤0.01% 3110
2013
Q2 		$1.28M Buy
+68,601
New +$1.25M ﹤0.01% 3096

Other funds holding NXGN

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's NXGN Position: Q4 2023 in Review

JP Morgan Chase sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 120,782 shares — an estimated $2.87M sold.

JP Morgan Chase first reported a position in NXGN in Q2 2013 and held it in 38 quarters. The position peaked at $39.1M in Q1 2022. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • JP Morgan Chase reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • JP Morgan Chase sold 120,782 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $2.87M.
  • JP Morgan Chase first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 38 quarters.
  • JP Morgan Chase's NextGen Healthcare, Inc. Common Stock position peaked at $39.1M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.